Lipocine Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LPCN research report →
Companywww.lipocine.com
Lipocine Inc. , a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs.
- CEO
- Mahesh V. Patel
- IPO
- 2013
- Employees
- 16
- HQ
- Salt Lake City, UT, US
Price Chart
Valuation
- Market Cap
- $13.00M
- P/E
- -1.33
- P/S
- 6.49
- P/B
- 0.67
- EV/EBITDA
- -0.66
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -8.21%
- Op Margin
- -605.86%
- Net Margin
- -571.10%
- ROE
- -66.69%
- ROIC
- -53.13%
Growth & Income
- Revenue
- $1.98M · -82.35%
- Net Income
- $-9,627,505 · -115371.85%
- EPS
- $-1.77 · -110725.00%
- Op Income
- $-10,371,379
- FCF YoY
- -644.34%
Performance & Tape
- 52W High
- $12.37
- 52W Low
- $1.81
- 50D MA
- $4.14
- 200D MA
- $4.76
- Beta
- 0.50
- Avg Volume
- 416.05K
Get TickerSpark's AI analysis on LPCN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 7, 26 | Higuchi John W. | buy | 40,000 |
| Apr 6, 26 | Higuchi John W. | buy | 123,000 |
| Apr 6, 26 | Patel Mahesh V. | buy | 25,000 |
| Apr 2, 26 | Patel Mahesh V. | buy | 25,000 |
| Jan 2, 26 | Patel Mahesh V. | other | 25,000 |
| Dec 18, 25 | Patel Mahesh V. | other | 8,629 |
| Dec 18, 25 | Fogarty Krista | other | 20,786 |
| Jun 4, 25 | Ono Richard Dana | other | 1,764 |
| Jun 4, 25 | Jene Jill M. | other | 1,764 |
| Jun 4, 25 | Papapetropoulos Spyros | other | 1,764 |
Our LPCN Coverage
We haven't published any research on LPCN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LPCN Report →